Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

• Status: Completed
• Trial end date: 2003-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy and Safety Study of MK0359 in Patients with Arthritis

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• You are 18-65 years of age and have Rheumatoid Arthritis

• You must be able to read and understand patient questionnaires

Exclusion Criteria:

• You have had certain types of surgery, certain types of cancer or history of Tuberculosis (TB) or HIV.